Maryland Emerging Infections Program

马里兰州新发感染项目（MD EIP）是马里兰州 卫生部（马里兰州卫生和心理卫生部，或“DHMH”），约翰霍普金斯 彭博公共卫生学院（JHSPH）和马里兰州大学巴尔的摩医学院 （UMSOM）。马里兰州于1997年成为国家EIP网络成员站点，在随后的七年中， 多年来，已经发展成为一个成熟的伙伴关系，能够进行积极的，以实验室为基础的监测 利用确定的监测人群，开展流行病学和实验室传染病相关 活动，并迅速应对新出现的传染病威胁。 MD EIP建议继续与CDC、其他联邦合作伙伴和其他EIP站点合作， 评估新出现的感染对公共卫生的影响，并作出反应。具体而言，MD EIP将 参与主动细菌核心监测（ABC）、食源性疾病主动监测网络 （粮食网）、监测呼吸道疾病和综合症、快速人口调查和人类 与基因组学有关的活动。除少数例外情况外，每项活动的服务范围将是 整个国家。MD EIP还建议在地理信息开发方面发挥领导作用 系统和空间分析模型，用于监测数据的可视化，假设的生成，以及 描述危险因素和病原体的共分布。MD EIP将继续加强其 通过继续对EIP工作人员进行交叉培训，迅速应对新出现的传染病问题的能力 并加强与其他伙伴的关系（例如公共卫生准备和反应）。各种 还将为感染控制从业人员、实验室工作人员、当地卫生人员提供培训机会， 部门工作人员、住院医师和公共卫生研究生。

The Maryland Emerging Infections Program (MD EIP) is a working partnership among Maryland's state health department (the Maryland Department of Health and Mental Hygiene, or"DHMH"), the Johns Hopkins Bloomberg School of Public Health (JHSPH), and the University of Maryland, Baltimore School of Medicine (UMSOM). Maryland became a national EIP network member site in 1997, and over the ensuing seven years, has developed into a mature partnership capable of performing active, laboratory-based surveillance using defined surveillance populations, conducting epidemiologic and laboratory infectious disease-related activities, and responding rapidly to emerging infectious disease threats. The MD EIP proposes to continue its collaboration with CDC, other federal partners, and other EIP sites to asess the public health impact of, and respond to, emerging infections. Specifically, the MD EIP will participate in Active Bacterial Core Surveillance (ABCs), Foodborne Diseases Active Surveillance Network (FoodNet), surveillance for respiratory diseases and syndromes, rapid population surveys, and human genomics-related activities. With few exceptions, the catchment area for each of these activities will be the entire State. The MD EIP also proposes to provide leadership in the development of geographic information systems and spatial analytic models for the visualization of surveillance data, generation of hypotheses, and description of the codistributions of risk factors and pathogens. The MD EIP will continue to enhance its capacity to quickly respond to newly emerging infectious disease issues by continuing to cross-train EIP staff and stengthen relationships with other partners (e.g. public health preparedness and response). A variety of training opportunities will also be provided for infection control practitioners, laboratorians, local health department staff, medical residents, and public health graduate students.